AIC
OVID icon

AWM Investment Company’s Ovid Therapeutics OVID Stock Holding History

AWM Investment Company’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-899,200
Closed -$1.47M – 109
2025
Q4 		$1.47M Buy
+899,200
New +$1.39M 0.14% 94

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

AWM Investment Company's OVID Position: Q1 2026 in Review

AWM Investment Company sold out of Ovid Therapeutics (OVID) in Q1 2026, closing a stake of 899,200 shares — an estimated $1.47M sold.

AWM Investment Company first reported a position in OVID in Q4 2025 and held it in 1 quarter. The position peaked at $1.47M in Q4 2025. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • AWM Investment Company reported no remaining Ovid Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AWM Investment Company sold 899,200 Ovid Therapeutics shares in Q1 2026, an estimated $1.47M.
  • AWM Investment Company first reported a position in Ovid Therapeutics in Q4 2025 and held it in 1 quarter.
  • AWM Investment Company's Ovid Therapeutics position peaked at $1.47M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.